The role of aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy.
Yue
D K
DK
Diabetes Services, Royal Prince Alfred Hospital, Sydney.
Brooks
B
B
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D000818:Animals; D003921:Diabetes Mellitus, Experimental / Q000150:complications; D003929:Diabetic Neuropathies / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D009281:Naphthalenes / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D051381:Rats
D009281:Naphthalenes; C040550:tolrestat; D000449:Aldehyde Reductase